News
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to ...
In its complete response letter, the FDA cited insufficient evidence establish deramiocel's effectiveness for cardiomyopathy ...
When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided an in-depth view | ...
Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...
The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...
Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are ...
One of the major complaints levied against FDA by the current administration is that the approval process is too complicated, takes too long, and needs to be modernized. The new leadership pledged to ...
HealthDay News — The US Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results